Health
Headlines
Get
the latest news in prevention and health matters. This
feature includes daily postings and recent archives to
keep you up to date on health reports and wires around
the world.
Weekly
Wellness
Get
informed with weekly wellness facts in a diversity of
health topics from prevention to fitness and nutrition.
Tips
Great
tips on what you need to know about keeping healthy and
active all year round.
Young Children Now Being
Targeted For Choleterol Drug Use
In an immediately controversial document, the American
Academy of Pediatrics (AAP) has recommended that children
as young as eight be treated with cholesterol-lowering statin
drugs.
The AAP's Committee on Nutrition released the guidelines
as part of a clinical report on childhood cardiovascular
health, published in the journal Pediatrics. It emphasized
reducing the risk of lifetime cardiovascular disease by
means of lifestyle interventions and cholesterol screening
starting from a young age.
Currently, young children are only given statins if they
suffer from genetic disorders such as familial hypercholesterolemia.
But the report recommends that children as young as eight
should be considered for treatment with cholesterol drugs
if they have LDL ("bad") cholesterol levels of 190 milligrams
per decaliter or higher. It also recommends that children
who have a family history or more than two other cardiovascular
risk factors should be considered for treatment if their
levels are 160 milligrams per decaliter or higher, as should
diabetic children with LDL levels of 130 milligrams per
decaliter and up.
"We know that in adults, decreasing cholesterol and giving
some of those drugs decreases risk of heart disease
or death," said AAP panel member Dr Nicolas Stettler, of
the Children's Hospital of Philadelphia. "So there's really
no reason to think that would be any different in children."
But critics have questioned this logic, saying that there
is not enough data to know if statins are safe or effective
in children.
The same drug often acts very differently among different
age groups.
"The guidelines are based on expert opinion, and they don't
have the level of evidence to support them that I would
like to see," said Thomas B. Newman, of the University of
California, San Francisco. "We don't know at what level
of cholesterol and what age the benefits of medication
exceed the risks and costs. We don't know what it means
to be on these medications for decades, and we don't know
whether there's an advantage to starting this young versus
starting as an adult."